Body Composition Characteristics Affecting Clinical Outcomes of Patients With Metastatic ccRCC Treated With Immune Checkpoint Blockade
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Associations between body composition features and clinical outcomes in metastatic clear cell renal cell carcinoma patients treated with immune checkpoint blockade
Clin. Cancer Res 2022 Oct 03;[EPub Ahead of Print], Y Ged, A Sanchez, S Patil, A Knezevic, E Stein, S Petruzella, K Weiss, C Duzgol, J Chaim, O Akin, M Mourtzakis, MT Paris, J Scott, F Kuo, R Kotecha, AA Hakimi, CH Lee, RJ Motzer, MH Voss, H FurbergFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.